chrisvoncsefalvay/vaers-outcomes huggingface dataset:
27OCT96 pt c/o body aches, cough, fever;2NOV96 c/o flu sx w/sore throat;4NOV96 MD saw pt stated had flu-?flu shot but would not say for sure that was rxn;6NOV96 pt states has allergy to chicken feathers;also has allergic asthma;
- Baby pale, quiet difficult to arouse apneic - all within 30 minutes of vaccine - was hospitalized overnight - sent home on apnea monitor  8/22/08 Reviewed hospital medical records for 7/28-7/31/08 admission. FINAL DX: immunization reactin Records reveal patient experienced good health on day of vaccination.  Immediately after vaccination cried but was consolable.  Within about 20 minutes had shallow respirations, pale & unresponsive.  Returned to office & noted to have decreased activity but returned to baseline quickly.  D/C to home.  Episode repeated & was admitted for observation & management.  Cardiac monitor revealed bradycardia & was irritable.  Oxygen sats 95-100%.  Remained stable & d/c to home w/continued w/u as outpatient.
Elevated heart rate off and on 12-18 hours after injection. My normal resting heart rate is around 50 and it was between 88-103 at times.  It subsided without medical care.
flu anyway with the shot; Initial information was received on 16-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional via social media..  This case involves female patient (age unspecified) who had flu anyway with the shot (influenza), while she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu with the shot (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Presented with worsening covid symptoms, diagnosed 4 days pta.  Dx with viral PNA.  Treated with abx, remdesivir, vit c and d.  D/C home
Received Anthrax vacination and shortly developed symptoms of fatigue, joint pain, sleep disorder, eye cosmetic changes, vision & hearing loss, tinnitis, carpal tunnel, dry/course skin, loss of concentration, vasomotor rhinitis, weight gain, and essential tremor.  Symptoms developed slowly after the course of 8 vaccines and 8 years.  Was diagnosed with Hashimoto's Disease and Hypothyroidism.  Have no family disposition to explain symptoms or onset other than vaccinations. Additonal coStart Codes added on 06/13/2005 from Medical Record: cough, hyperholesteremia, dyspepsia, pharyngitis, pain chest. 01/04/10 Hashimoto's Thyroiditisi with hypothyroidism. Dry flaky skin and scalp, fatigue, weakness, lethargy, sleepiness, muscle cramps, joint pain, muscle aches, brain fog, loss of concentration, slow thinking, nasal congestion, post-nasal drip, heavy snoring; Vasomotor (hormonal) Rhinitis, cough, sore throat, enlarged thyroid, swollen lymph glands, continued weight gain>20lbs, frequent eye infection and styes, conjunctivitis, essential tremor, intolerance to heat or temperature changes, headaches, Aphthous ulcers, mouth sore, heart palpitiations and dizziness.
Weird white swollen line just below lower lip  Twitching between eye/ lower forehead
This case was reported by a consumer and described the occurrence of cough in a 62-year-old female patient who received SHINGRIX (batch number 3S354, expiry date 4th July 2020) for prophylaxis. On 3rd May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In May 2018, 14 days after receiving SHINGRIX, the patient experienced cough, fever, general body pain, muscle pain, headache, lethargy, cold sores lip and palpitation. On an unknown date, the outcome of the cough and fever were recovered/resolved and the outcome of the general body pain, muscle pain, headache, lethargy, cold sores lip and palpitation were recovering/resolving. The reporter considered the cough, fever, general body pain, muscle pain, headache, lethargy, cold sores lip and palpitation to be related to SHINGRIX. Additional details were provided as follows: The patient experienced severe cough and fever for 5 days, body aches, muscle pain, headache, lethargy, cold sore under lip skin and heart palpitation. This case has been linked with US2018GSK173028 (2nd dose of SHINGRIX), reported by same reporter for same patient.
Patient didn't have any side effects initially; however on the 10th patient broke out in rash starting on the head and torso and then completely covering body that resembles chicken pox. she is following up with doctor however rash is super itchy and doesn't resemble shingles
PATEINT REPORTED TO MD AT F/U APPT 6/08 THAT SHE HAD EXPERIENCED ADVERSE REACTION  AFTER BOTH GARDASIL INJECTIONS IN MARCH,2008 AND MAY 2008. REACTION INCLUDED FATIGUE,FEVER, LISTLISSNESS LESS THAN 24 HOURS AFTER RECEIVING INJECTIONS LASTING ABOUT 4- 5 DAYS. PATIENT FOLLOWED UP WITH PRIMARY CARE PHYSICIAN RATHER THAN THROUGH HER GYN PHYSICIAN AND DID NOT MAKE OFFICE AWARE THAT SHE HAD HAD AN ADVERSE REACTION AFTER IST VACCINE
Information has been received from an unspecified health professional via other company (#64664) referring to a 53 year old female patient. Information regarding relevant medical history and concurrent condition were not reported. On 11-MAY-2015 the patient was vaccinated with PNEUMOVAX 23 (dose and route not reported, lot # K020215, expiration date 31-MAY-2016) at routine office visit. When she received the vaccine, the patient's arm was extremely painful. She could not lift her arm. The patient was given DEPO-MEDROL shot for symptoms and was told to follow up if not better. The outcome of the events was unknown. This is one of several reports received from the same source Additional information has been requested.
get forgetful; This case was reported by a consumer via interactive digital media and described the occurrence of forgetfulness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced forgetfulness. On an unknown date, the outcome of the forgetfulness was unknown.   It was unknown if the reporter considered the forgetfulness to be related to Shingrix.  Additional details were provided as follows:  The patient received shingrix shot. The patient was very forgetful about a lot of things ever.
Initial report received on 21/Aug/2006 from a health care professional. A 55-year-old female, with a history of rheumatoid arthritis, had received an intramuscular, left deltoid injection of Decavac, lot number U1786DA, on 14/Aug/2006. The vaccination was the patient's ten year booster. Seven days post-vaccination, the patient developed bruising over her left arm. tenderness and swelling at the injection site. She was examined " in the office"  on the same day. Liver function tests and a CBC were ordered, but results were not provided. Concomitant medications included methotrexate, Advil folic acid and Tylenol # 3. At the time of this report, the patient had not recovered. Follow-up information received on 20/Sep/2006 from a physician. The event involved the "mediolateral aspect of the upper arm and up to left medial epicondyle," The reporter also notes "associated with severe pain." The patient was subsequently examine by a physician. CBC and liver function test were normal. The onset date for the event was amended to 19/Aug/2006, five days post-vaccination. The patient recovered in three weeks from the time of vaccination.
constant crying for 3 to 4 hr;fever of 101.5;this is the rxn to DTP/HIB:
Admitted for shortness of breath, abdominal pain, A fib with RVR, COVID-19 test negative
After feeling OK for six weeks I felt like I was getting a normal reaction to the flu ? headache, achey legs, sensitive skin ? which cleared up after I took oscillococcinum; but then Saturday 3/27 my chest felt constricted and by Sunday I couldn't get my full breath. After being extremely low-energy all this time it occurred to me to take a reading on our oximeter and it momentarily registered 83, then 86, and came to rest at 91-92. I took a reading a little later and it was 95. I felt fine Tuesday morning but ran out of gas about noon. Then yesterday (Wednesday) morning everything seemed normal and has remained so. Now my reading is 97-98.
5 hrs later had chills, shaking, could not walk, pain in left leg severe, pains in joints fever 101 degrees, weak, not able to walk. Wanted to go to hospital felt so bad. Vomited, headache, next day and slept all day. We didn't know it after shot that got for over 65 yrs old. Monday rec'd it, Wednesday felt better.
Headaches for 3 weeks after shot. Unknown if possible side effect but swelling in quads off and on weeks after and recur monthly switching sides, and increased lower body mainly leg injuries all within the same time, calf strain, tearing of quad muscles, plantar pain on both sides, long lasting swelling in those regions too that require medication.
Fever, dizziness to point of blacking out, nausea, ER visit 4/30/21 due to heart racing, lightheadedness
At first only my arm was sore. Then the next day I was extremely exhausted - despite getting a good night sleep.  On Saturday, I was severely nauseated, dizzy and complete loss of appetite and energy. I felt very sleepy and vomiting after drinking any liquids: water, broth, and tea.  Symptoms disappeared by Sunday - but still a little dizzy through the day.  I am fine, just reporting for your records.
The patient presents to the clinic after receiving the vaccine about 10 days ago. Three days after that he noticed an increase in his pulse while at rest. Evaluation at PCP showed mild increase in QRS, possibly representing a mild case of myocarditis. Discussed watchful waiting as symptoms do seem to be improving over the last few days.
open wound on underside of arm approx 5-6 hours after vaccination.  Evaluated by telehealth visit with PCP- started on an antibiotic
Numbness fingers-Abd pain. Acute pain (R) leg. Unable to walk-no feeling (L) leg. Unable to stand. Guillain Barre.
The patient came to the pharmacy for the COVID-19 bivalent vaccine and received the regular vaccine.
RARE BLOOD CLOTS; This spontaneous report received from a consumer via a company representative concerned an adult female (older than 50 years) of unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry: unknown) dose, therapy start date not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient had rare blood clots (Clot blood) and died. It was unknown if autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of rare blood clots was reported as fatal. This report was serious (Death). This case, from the same reporter is linked to 20210654540, 20211010045, 20210446964 and 20211023372.; Sender's Comments: V0:20211140935- covid-19 vaccine ad26.cov2.s -rare blood clots. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: RARE BLOOD CLOTS
Patient was administered 3rd dose of moderna vaccine. The vaccine was #22 drawn out of a vial. Should not have been any more than 20 drawn from vial
Patient was administered 0.25 cc of the 6-11 yo Moderna vaccine, this resulted in the patient receiving half the dose that they should have received
Patient has an encircled area on her left proximal triceps region where there was previously noted by ER induration and a central area of thickening.  This area has faded compared to previously described on reports from the emergency room hand is still somewhat tender to touch in the central area around the site of the injection.  --There is no signs of the ascending cellulitis--  The patient is a very pleasant 65 year old female who comes in 2 days after she received a PNEUMOVAX injection.  She feels like she is getting a cellulitis.  She has felt some chills, no documented fever but somewhat sweaty yesturday.  Those symptoms have somewhat improved but she has noticed increases redness to her left upper arm and came in for further evaluation.
During the dose, I was having a cough and didn't think much, the next day I had more cough, the next day I felt off, the next day I took a home test and I had it. That's when I got the Paxlovid. The symptoms were quite mild. I was sort of tired and I had appetite. I was still feeling tired on Friday. Saturday, I started feeling sick. I did not have a fever. I started feeling like a little clammy - sweat and felt anxious. Then really anxious and did not usually have this and I was not comfortable anymore. I got into bed and was too hot and I walked outside and just became more anxious. I called and talked to the nurse practitioner. I was told to go to the ER, I called for an ambulance, and they took my vitals. I chose not to go to the hospital. I called them back and asked to go to the ER. They took my vitals and text and gave me Valium and other pills. Then I slept for a while, and it all happened again. I drove myself this time on 9/19/22. They gave me another medication to calm done. I took one more valium and got better eventually. Tested positive for COVID-19 on 9/12/22
Reports swelling/tingling of lips to 2nd dose. For 1st dose, reported same, swelling of lips 2 hours after.  EMT called to assess pt.   Vitals taken.   No other symptoms.
Pt received quadrivalent 2013-2014 flu shot. Walked into pharmacy with parents and sister. Fell on the floor right outside pharmacy.
This spontaneous report as received from two pharmacists refers to a patient of unknown age and gender. On 22-APR-2014, the patient was vaccinated with a dose of improperly stored ZOSTAVAX, lot # J013451, expiration date 24-JAN-2014 (dose and route not reported) with worst case exposure of 34F for 458 hours, Dates of excursions: 06-MAR-2014 to 22-APR-2014. No adverse effects were reported. This is one pf several reports received from the same source. Additional information has been requested.
My periods were becoming more frequent and heavier. Periods lasted 30 days to 24 days. And Then there was major blood clotting post booster shot. Dr. did blood work, ultrasound, and biopsy and nothing remarkable came about these tests. My doctor sent a prescription of Provera for ten days to stop heavy bleeding. I began to bleed heavily again on 02/9/2022 and on  02/12/2022, I was admitted to the emergency room and upon tracking my blood level 12.7 hemoglobin and then within 3 hours it got down 10 hemoglobin count due to over bleeding. I was admitted to the hospital and got scheduled a DNC dilation, and around 02:00PM I was in the procedure. I did have 2 rounds of IV estrogen which helped with slowing the bleeding. By the time that I was discharged it was down to 9 hemoglobin count. I was given sprintec birth control to help with the bleeding and now at this point the symptoms have gone from active bleeding to now spotting. I did meet with my OBGYN and they are going to place an implant birth control on 3-1-2022.
The next morning after I woke up to my arm sore at the injection site. Brain fog, chills but no fever and a headache on one side of my head all of which lasted about 48hrs. On 12/21 I developed a cough and sinus congestion so on 12/22 I took a home rapid COVID test and was positive for COVID and to date I am under quarantine.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported. On 17-AUG-2015, the patient was vaccinated with an unknown dose of ZOSTAVAX (route, lot# and expiry date were not reported), but the pharmacist was not sure if she fully reconstituted the vaccine prior to administration it to the patient and was not sure if the patient received a full dose of the vaccine as a result. The pharmacist reported that the issue was caused by use error. No adverse symptoms were reported. Follow up information has been received from the pharmacist on 23-OCT-2015. The patient was a 60 year old female, who was vaccinated with ZOSTAVAX in the left arm (lot# L011533 expiration date unknown) on 17-AUG-2015. Additional information is not expected as all follow up request to complete this report has been received Patient information, product information and narrative were updated.
24 hours post vax, the pt developed a high fever, irritability, and lethargy. Diagnosed with positive blood culture with coag negative staph.
Patient recieved her first dose of the Moderna Vaccine at 13:30. Aroung 13:45 patient stated to have a metalic taste in her mouth, felt naseated, flush and had a rash on her chest. Patient stated that she had eaten prior to getting her vaccine. EMS on scene. BP was 186/109, P- 128, Resp- 18, o2 sat 96% RA, Blood Sugar was 97.  14:04 Benedryl 50mg IM was given in Rt arm by EMS. 14:10 BP- 162/108, P-100, 02- 99   4 lead EKG taken SR 14:17 - 18g Lt A/C placed 14:18 - 4mg Zofram IV given for Nasea  14:22 - BP- 199/113, P- 131  14:25 - EPI 0.3mg IV given  14:28 - 114/92, HR- 123, 02 100% RA 14:30 - Rash gone and patient trasported to hosptial by EMS
pt had pink maculo papular rash on torso-not on arms & legs;up into hair line sl temp;
I?m not sure if it?s too important but I had Covid previously and got extreme aches and chills. I couldn?t get up without feeling like my whole body was attacking me and I was attempting to brush my teeth and my legs wouldn?t stay up straight.
Information has been received from a nurse concerning a female "in her teens" who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (dose, route and lot number not reported). About a month ago, in approximately June 2009, "after receiving the vaccine, the patient developed a rash". The patient recovered from rash on an unspecified date. It was not specified if the patient sought medical attention. Additional information has been requested.
Headache; Fatigue; General body aches; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headache), FATIGUE (Fatigue) and MYALGIA (General body aches) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm), FATIGUE (Fatigue) and MYALGIA (General body aches). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headache), FATIGUE (Fatigue) and MYALGIA (General body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       After receiving vaccine, the patient experienced pain in arm, fatigue, general body aches and headaches.  Concomitant medications were not reported.  No treatment details were provided
17year old patient given first dose of vaccine; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17year old patient given first dose of vaccine) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17year old patient given first dose of vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17year old patient given first dose of vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.No treatment information was provided.
Patient was given pneumococcal 0.1ml IM for PPD. Redness at site. No treatment required. 1"x1" slight redness. No fever.
Uncontrolled muscle fasciculations in the left deltoid.  Contraction duration was less than one second per event, but up to 10  events per minute.
She felt the "plunger was sticking". The plunger required the use of more force that usual to prime.; She felt the "plunger was sticking". The plunger required the use of more force that usual to prime.; The plunger required the use of more force that usual to prime and the product became "unstuck" after applying pressure which forced "most of the medication" to empty from the syringe.; The plunger required the use of more force that usual to prime and the product became "unstuck" after applying pressure which forced "most of the medication" to empty from the syringe.; This spontaneous report was received from a nurse via company representative and refers to a female patient of unknown age who was also a nurse. Information regarding the patient's medical history,concurrent conditions and concomitant medications was not provided. IIt was reported that nurse removed the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # T007024 with expiration date 23-APR-2022, pre-filled syringe from refrigerator to prepare to administer to a patient, but felt the "plunger was sticking". Caller states the nurse reported the plunger required the use of more force that usual to prime and the product became "unstuck" after applying pressure which forced "most of the medication" to empty from the syringe. Caller also informed Agent that she spoke with nurse and she informed that she was not sure but she does believe that the product was dispensed on her because the product shot everywhere. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T007024; expirationdate: 23-APR-2022; deviceage and unit: 0 ; malfunction: Unknown; productavailableforevaluation: No; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability